12036349 |
3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency
Taylor, JS,
Gallicchio, SN,
Bhimnathwala, H,
Zartman, CB,
Huber, HE,
Graham, SL,
Gibbs, JB,
Huff, JR,
Buser, CA,
Hartman, GD,
Ellis-Hutchings, M,
Abrams, M,
Heimbrook, DC,
Koblan, KS,
Lynch, JJ,
Kohl, NE,
Beese, LS,
Williams, TM,
Fernandes, C,
Bell, IM,
Walsh, ES,
Hamilton, KA,
Beshore, DC,
Rodrigues, AD,
Davide, J,
Lobell, RB,
Culberson, JC,
Homnick, CF,
Kassahun, K,
Bogusky, MJ,
Robinson, R
|
J. Med. Chem. |
2002 |
12825937 |
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents
Taylor, JS,
Robinson, RG,
Kohl, NE,
Beese, LS,
Tsou, NN,
Graham, SL,
Huber, HE,
Buser, CA,
Fernandes, C,
Walsh, ES,
Hamilton, KA,
deSolms, SJ,
MacTough, SC,
Ellis-Hutchings, M,
Shaw, AW,
Lobell, RB,
Ciccarone, TM
|
J. Med. Chem. |
2003 |